The Druggist of Auschwitz: A Documentary Novel
Description:
The Druggist of Auschwitz is a frighteningly vivid portrayal of the Holocaust as seen through the eyes of criminal and victim alike. Adam, "the last Jew of Schäßburg," recounts with disturbing clarity his imprisonment at the infamous Auschwitz concentration camp. Through his fictional narrative and excerpts of actual testimony at the Frankfurt Auschwitz Trial of 1963--1965, we come to learn the true-life story of Dr. Victor Capesius, who, despite strong friendships with Jews, was quick to profit from their tragedy once the Nazis came to power. Interspersed with historical research and interviews with actual survivors, The Druggist of Auschwitz is a vital and unique addition to our understanding of the Holocaust.
Best prices to buy, sell, or rent ISBN 9781250002372
Related Books
- 1
- 2
- Capesius, der AuschwitzapothekerSchlesak, DieterISBN-13:9783801203696
- The Druggist of Auschwitz: A Documentary NovelSchlesak, DieterEdition:Complete Numbers Starting with 1, 1st EdISBN-13:9780374144067
- Capesius, der AuschwitzapothekerSchlesak, DieterISBN-13:9783801203696
- The Druggist of Auschwitz: A Documentary NovelSchlesak, DieterEdition:Complete Numbers Starting with 1, 1st EdISBN-13:9780374144067
Frequently Asked Questions about The Druggist of Auschwitz: A Documentary Novel
The price for the book starts from $7.68 on Amazon and is available from 19 sellers at the moment.
If you’re interested in selling back the The Druggist of Auschwitz: A Documentary Novel book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the The Druggist of Auschwitz: A Documentary Novel book, the best buyback offer comes from and is $ for the book in good condition.
The The Druggist of Auschwitz: A Documentary Novel book is in very low demand now as the rank for the book is 2,391,452 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.